VERA FY 2023 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

VERAVera Therapeutics, Inc.

$3B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$102M

Net Income

-$96M

EPS (Diluted)

$-2.25

Cash Flow

Operating Cash Flow

-$92M

Free Cash Flow

-$92M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$176M

Total Liabilities

$74M

Stockholders' Equity

$102M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$846,000	-100.0%
Operating Income	-$102M	-$91M	-12.2%
Net Income	-$96M	-$89M	-7.8%